• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Isoxazoles

5-Cyclohexyl-1,2-Oxazole-3-Carboxylic Acid: A Comprehensive Overview

The compound 5-cyclohexyl-1,2-oxazole-3-carboxylic acid, identified by the CAS number 908856-66-6, is a fascinating molecule with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of oxazole derivatives, which have been extensively studied due to their unique chemical properties and biological activities. The structure of 5-cyclohexyl-1,2-oxazole-3-carboxylic acid comprises a cyclohexyl group attached to the 5-position of the oxazole ring, along with a carboxylic acid group at the 3-position. This combination of functional groups imparts the molecule with versatile reactivity and functional versatility.

Recent studies have highlighted the importance of oxazole derivatives in drug discovery and development. The presence of the oxazole ring in 5-cyclohexyl-1,2-oxazole-3-carboxylic acid contributes to its ability to engage in hydrogen bonding and π-interactions, which are critical for molecular recognition and binding in biological systems. The cyclohexyl group adds steric bulk and hydrophobicity to the molecule, enhancing its solubility properties and potentially improving its bioavailability when used as a drug candidate.

In terms of synthesis, 5-cyclohexyl-1,2-oxazole-3-carboxylic acid can be prepared through various methods, including cyclization reactions involving amino acids or other suitable precursors. One notable approach involves the condensation of amines with carbonyl compounds under specific reaction conditions to form the oxazole ring. The introduction of the cyclohexyl group typically requires careful planning to ensure regioselectivity and optimal yields.

The biological activity of 5-cyclohexyl-1,2-oxazole-3-carboxylic acid has been explored in recent research studies. For instance, investigations into its anti-inflammatory and antioxidant properties have shown promising results, suggesting potential applications in treating conditions associated with oxidative stress and inflammation. Additionally, this compound has demonstrated moderate inhibitory activity against certain enzymes, making it a candidate for further exploration in enzyme-targeted therapies.

The pharmacokinetic profile of 5-cyclohexyl-1,2-oxazole-3-carboxylic acid is another area of interest for researchers. Studies have indicated that its hydrophobic nature may influence its absorption and distribution characteristics within the body. However, further research is needed to fully understand its pharmacokinetics and toxicity profiles before it can be considered for clinical use.

In conclusion, 5-cyclohexyl-1,2-oxazole-3-carboxylic acid, CAS number 908856

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)